# EDGAR Filing Document

**Accession Number:** 0001534881
**File Stem:** 0001398344-23-000046
**Filing Date:** 2023-1
**Character Count:** 3888
**Document Hash:** 943e7a9c500755ebf5361ad6fd6d9d0c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001398344-23-000046.hdr.sgml**: 20230103

**ACCESSION NUMBER**: 0001398344-23-000046

**CONFORMED SUBMISSION TYPE**: 497

**PUBLIC DOCUMENT COUNT**: 14

**FILED AS OF DATE**: 20230103

**DATE AS OF CHANGE**: 20230103

**EFFECTIVENESS DATE**: 20230103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aspiriant Trust
- **CENTRAL INDEX KEY:** 0001534881
- **IRS NUMBER:** 205458457
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** 497
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-178600
- **FILM NUMBER:** 23501655

**BUSINESS ADDRESS:**
- **STREET 1:** 11100 SANTA MONICA BOULEVARD SUITE 600
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90025
- **BUSINESS PHONE:** (310) 806-4000

**MAIL ADDRESS:**
- **STREET 1:** 11100 SANTA MONICA BOULEVARD SUITE 600
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90025

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Aspiriant Global Equity Trust
- **DATE OF NAME CHANGE:** 20111214

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Advanced Global Equity Trust
- **DATE OF NAME CHANGE:** 20111213

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Advanced Capital Intelligence LLC
- **DATE OF NAME CHANGE:** 20111115

## Series and Classes Contracts Data

### Aspiriant Defensive Allocation Fund (Series ID: S000051603)

---

|  |  |  |
|:---|:---|:---|
| Class Name                          | Ticker Symbol | Class ID   |
| Aspiriant Defensive Allocation Fund | RMDFX         | C000162347 |

---

## Series and Classes Contracts Data

### Aspiriant Defensive Allocation Fund (Series ID: S000051603)

| Class ID   | Class Name                          | Ticker Symbol   |
|:---|:---|:---|
| C000162347 | Aspiriant Defensive Allocation Fund | RMDFX           |

?xml version="1.0" encoding="utf-8"?

**Aspiriant Trust**

**Aspiriant Defensive Allocation Fund**

**Supplement dated January 3, 2023**

**to the Prospectus and Statement of Additional Information dated August 1, 2022**

**This supplement updates information in the Prospectus and Statement of Additional Information ("SAI") for the Aspiriant Defensive Allocation Fund (the "Fund") and should be read in conjunction with those documents.**

Effective immediately, the Fund's fundamental investment policy regarding diversification is eliminated, thereby changing the Fund's classification from a diversified investment company to a non-diversified investment company under the Investment Company Act of 1940. The elimination of the Fund's diversification policy permits greater flexibility in the investment management of the Fund with respect to investments in foreign funds, private funds, and other types of funds, thereby allowing more of the Fund's portfolio to be invested in such funds and a greater percentage of assets to be invested in any one fund.

To the extent the Fund invests in a relatively small number of issuers, a decline in the market value of a particular issuer held by the Fund may affect its value more than if it invested in a larger number of issuers and the value of the Fund's shares may be more volatile than the values of shares of more diversified funds. As a fund of funds that invests in various asset classes, however, the Fund invests in various types of underlying funds whose portfolio securities generally are numerous and offer a range of strategies. The change does not affect the Fund's investment objective or overall investment strategy or risks as the Fund would continue to invest in a broad range of asset classes.

Shareholders of record approved the elimination of the Fund's diversification policy at a special meeting held today. The information in the Fund's Prospectus and SAI, therefore, is hereby revised in accordance with the information in this supplement.

***Please retain this supplement for future reference.***

 ****